Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
JAMA Network Open|June 10, 2022
Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019Mark P Lythgoe, Aakash Desai, Bishal Gyawali, et al.
Trials|January 6, 2022
Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE)Consuelo Nóhpal de la Rosa, Jonathan Krell, Emily Day, et al.
AJR. American Journal of Roentgenology|February 26, 2013
The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancerBelinda Lee, Adrian K Lim, Jonathan Krell, et al.
Nucleic Acids Research|January 28, 2017
Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFRLeandro Castellano, Aleksandra Dabrowska, Loredana Pellegrino, et al.
Expert Review of Molecular Diagnostics|June 5, 2019
Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?Daniel S K Liu, Mireia Mato Prado, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|May 4, 2013
Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical useAdam E Frampton, Tamara M H Gall, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|June 21, 2013
Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancerAdam E Frampton, Claire E Fletcher, Tamara Mh Gall, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Cancers|October 30, 2020
Size-Exclusion Chromatography as a Technique for the Investigation of Novel Extracellular Vesicles in CancerDaniel S K Liu, Flora M Upton, Eleanor Rees, et al.
Cancer|March 27, 2014
Brain metastases associated with germ cell tumors may be treated with chemotherapy aloneAnna Hardt, Jonathan Krell, Peter D Wilson, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
JAMA Network Open|June 10, 2022
Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019Mark P Lythgoe, Aakash Desai, Bishal Gyawali, et al.
Trials|January 6, 2022
Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE)Consuelo Nóhpal de la Rosa, Jonathan Krell, Emily Day, et al.
AJR. American Journal of Roentgenology|February 26, 2013
The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancerBelinda Lee, Adrian K Lim, Jonathan Krell, et al.
Nucleic Acids Research|January 28, 2017
Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFRLeandro Castellano, Aleksandra Dabrowska, Loredana Pellegrino, et al.
Expert Review of Molecular Diagnostics|June 5, 2019
Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?Daniel S K Liu, Mireia Mato Prado, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|May 4, 2013
Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical useAdam E Frampton, Tamara M H Gall, Elisa Giovannetti, et al.
Expert Review of Molecular Diagnostics|June 21, 2013
Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancerAdam E Frampton, Claire E Fletcher, Tamara Mh Gall, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Cancers|October 30, 2020
Size-Exclusion Chromatography as a Technique for the Investigation of Novel Extracellular Vesicles in CancerDaniel S K Liu, Flora M Upton, Eleanor Rees, et al.
Cancer|March 27, 2014
Brain metastases associated with germ cell tumors may be treated with chemotherapy aloneAnna Hardt, Jonathan Krell, Peter D Wilson, et al.
Pageof 14